These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22689061)

  • 1. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.
    Huang JM; Nagatomo I; Suzuki E; Mizuno T; Kumagai T; Berezov A; Zhang H; Karlan B; Greene MI; Wang Q
    Oncogene; 2013 Apr; 32(17):2220-9. PubMed ID: 22689061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
    Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F
    J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity.
    Michaloglou C; Lehmann W; Martin T; Delaunay C; Hueber A; Barys L; Niu H; Billy E; Wartmann M; Ito M; Wilson CJ; Digan ME; Bauer A; Voshol H; Christofori G; Sellers WR; Hofmann F; Schmelzle T
    PLoS One; 2013; 8(4):e61916. PubMed ID: 23613971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.
    Lee BS; Park DI; Lee DH; Lee JE; Yeo MK; Park YH; Lim DS; Choi W; Lee DH; Yoo G; Kim HB; Kang D; Moon JY; Jung SS; Kim JO; Cho SY; Park HS; Chung C
    Biochem Biophys Res Commun; 2017 Sep; 491(2):493-499. PubMed ID: 28684311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function.
    Wilson KE; Li YW; Yang N; Shen H; Orillion AR; Zhang J
    J Biol Chem; 2014 Aug; 289(34):23693-700. PubMed ID: 25023289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
    Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
    J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPN14 interacts with and negatively regulates the oncogenic function of YAP.
    Liu X; Yang N; Figel SA; Wilson KE; Morrison CD; Gelman IH; Zhang J
    Oncogene; 2013 Mar; 32(10):1266-73. PubMed ID: 22525271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling.
    Wang R; Du Y; Shang J; Dang X; Niu G
    Mol Cell Probes; 2020 Oct; 53():101642. PubMed ID: 32645410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPN14 is required for the density-dependent control of YAP1.
    Wang W; Huang J; Wang X; Yuan J; Li X; Feng L; Park JI; Chen J
    Genes Dev; 2012 Sep; 26(17):1959-71. PubMed ID: 22948661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.
    Komuro A; Nagai M; Navin NE; Sudol M
    J Biol Chem; 2003 Aug; 278(35):33334-41. PubMed ID: 12807903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling.
    Campbell KN; Wong JS; Gupta R; Asanuma K; Sudol M; He JC; Mundel P
    J Biol Chem; 2013 Jun; 288(24):17057-62. PubMed ID: 23667252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP promotes erlotinib resistance in human non-small cell lung cancer cells.
    Hsu PC; You B; Yang YL; Zhang WQ; Wang YC; Xu Z; Dai Y; Liu S; Yang CT; Li H; Hu B; Jablons DM; You L
    Oncotarget; 2016 Aug; 7(32):51922-51933. PubMed ID: 27409162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level.
    Omerovic J; Puggioni EM; Napoletano S; Visco V; Fraioli R; Frati L; Gulino A; Alimandi M
    Exp Cell Res; 2004 Apr; 294(2):469-79. PubMed ID: 15023535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.
    Iglesias-Bexiga M; Castillo F; Cobos ES; Oka T; Sudol M; Luque I
    PLoS One; 2015; 10(1):e0113828. PubMed ID: 25607641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
    Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
    Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.
    Yang Y; Ma Q; Li Z; Wang H; Zhang C; Liu Y; Li B; Wang Y; Cui Q; Xue F; Ai D; Zhu Y; He J
    Br J Pharmacol; 2021 Apr; 178(7):1524-1540. PubMed ID: 33474722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.
    Yang C; Tan J; Zhu J; Wang S; Wei G
    Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression.
    Ma K; Xu Q; Wang S; Zhang W; Liu M; Liang S; Zhu H; Xu N
    Cancer Lett; 2016 May; 375(1):84-91. PubMed ID: 26944315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.